Wealth Architects, LLC Pfizer Inc Transaction History

Wealth Architects, LLC

$963 Million
Q3 2025

A detailed history of Wealth Architects, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wealth Architects, LLC holds 8,935 shares of PFE stock, worth $224,089. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,935

Holding current value

$224,089

% of portfolio

0.02%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$23.29 - $25.88 $208,096 - $231,237	8,935 New	8,935 $227,000
Q1 2025 May 14, 2025	BUY	$25.01 - $27.13 $419,917 - $455,512	16,790 Added 287.3%	22,634 $573,000
Q1 2025 May 12, 2025	SELL	$25.01 - $27.13 $107,893 - $117,038	-4,314 Reduced 42.47%	5,844 $148,000
Q4 2024 Feb 10, 2025	SELL	$24.8 - $30.19 $47,343 - $57,632	-1,909 Reduced 15.82%	10,158 $269,000
Q3 2024 Oct 31, 2024	SELL	$27.7 - $31.39 $26,730 - $30,291	-965 Reduced 7.4%	12,067 $349,000
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $20,410 - $23,916	-808 Reduced 5.84%	13,032 $364,000
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $4,297 - $4,935	166 Added 1.21%	13,840 $384,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $46,328 - $60,175	-1,773 Reduced 11.48%	13,674 $393,000
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $64 - $75	2 Added 0.01%	15,447 $512,000
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $36,517 - $42,249	1,011 Added 7.0%	15,445 $566,000
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $5,553 - $7,230	-141 Reduced 0.97%	14,434 $588,000
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $14,028 - $18,312	-336 Reduced 2.25%	14,575 $747,000
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $6,432 - $7,852	-147 Reduced 0.98%	14,911 $653,000
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $19,216 - $22,785	413 Added 2.82%	15,058 $789,000
Q1 2022 May 17, 2022	SELL	$45.75 - $56.69 $53,253 - $65,987	-1,164 Reduced 7.36%	14,645 $758,000
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $47,765 - $70,805	1,156 Added 7.89%	15,809 $934,000
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $14,287 - $18,352	364 Added 2.55%	14,653 $630,000
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $98,824 - $111,951	2,752 Added 23.85%	14,289 $560,000
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $669 - $755	-20 Reduced 0.17%	11,537 $418,000
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $2,209 - $2,808	66 Added 0.57%	11,557 $425,000
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $26,638 - $31,252	839 Added 7.88%	11,491 $422,000
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $13,282 - $16,114	441 Added 4.32%	10,652 $348,000
Q1 2020 Apr 23, 2020	BUY	$27.03 - $38.62 $32,895 - $47,000	1,217 Added 13.53%	10,211 $333,000
Q4 2019 Jan 28, 2020	SELL	$32.92 - $37.36 $14,846 - $16,849	-451 Reduced 4.78%	8,994 $352,000
Q3 2019 Oct 23, 2019	SELL	$32.49 - $42.13 $5,003 - $6,488	-154 Reduced 1.6%	9,445 $339,000
Q2 2019 Jul 12, 2019	BUY	$36.98 - $41.52 $41,713 - $46,834	1,128 Added 13.32%	9,599 $416,000
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $34,050 - $37,409	-908 Reduced 9.68%	8,471 $360,000
Q4 2018 Jan 17, 2019	BUY	$38.47 - $43.86 $19,927 - $22,719	518 Added 5.85%	9,379 $409,000
Q3 2018 Oct 04, 2018	BUY	$34.47 - $41.81 $18,200 - $22,075	528 Added 6.34%	8,861 $391,000
Q2 2018 Jul 19, 2018	BUY	$32.98 - $35.16 $8,805 - $9,387	267 Added 3.31%	8,333 $302,000
Q1 2018 Apr 13, 2018	SELL	$31.91 - $37.02 $67,617 - $78,445	-2,119 Reduced 20.81%	8,066 $286,000
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $10,144 - $10,763	-305 Reduced 2.91%	10,185 $369,000
Q3 2017 Nov 08, 2017	SELL	$31.0 - $34.15 $3,596 - $3,961	-116 Reduced 1.09%	10,490 $374,000
Q2 2017 Aug 10, 2017	BUY	N/A	10,606	10,606 $356,000

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.57B

Call Options Held

87.2M

Put Options Held

106M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.

Account

Wealth Architects, LLC Pfizer Inc Transaction History